DEC 29, 2019 8:37 AM PST

How close are we to a simple blood test for Parkinson's Disease?

WRITTEN BY: Tara Fernandez

Parkinson’s Disease (PD) alters nerve cells in the brain that produce the neurotransmitter dopamine. Famously regarded as the “happiness” hormone, dopamine plays several other behavioral and physical functions, including regulating mood, heart rate and movement.

Due to the dysregulation of dopamine’s functions, motor coordination, speech and gait are all compromised in PD patients, with the majority of patients being around 60 years old or older. The disease was first documented by English surgeon James Parkinson in 1817, but 200 years later, we are still in the dark about the molecular events that give rise to PD.

Besides seeking medical attention upon noticing the tell-tale signs of the condition -- tremors, cognitive problems, and issues with balance -- there is no definitive diagnostic test. Affected individuals present with a varied spectrum of symptoms, from motor complications to purely cognitive problems like dementia. Neurologists typically send individuals suspected of having the disease for a battery of tests, from CT scans to physical examinations, none of which provide conclusive answers.

Recently published research funded by the Michael J. Fox Foundation demonstrated the potential for measuring alpha-synuclein levels in the blood as a potential PD diagnostic test. Alpha-synuclein is a protein that is naturally abundant in the brain, thought to play a role in neurotransmitter function, though scientists are still investigating its precise cellular function.

Within the neuron, levels of alpha-synuclein are tightly regulated and undergo a continuous process of degradation and recycling in response to changes in their environment. Patients with neurodegenerative diseases have high levels of an abnormal form of alpha-synuclein, aggregated in clumps called Lewy bodies. This is believed to be due to an imbalance in the delicate balance of alpha-synuclein production and removal, resulting in a pathological accumulation of the protein, as illustrated in the video below. 

 

 

Alpha-synuclein is also found in the blood, secreted by red blood cells, though its function here, and connection to the onset of neural diseases are still unknown. 

To test the hypothesis that circulating alpha-synuclein levels could act as a simple diagnostic biomarker, researchers collected blood samples from 46 PD patients and 45 healthy controls. The patient group was further split into two subgroups: one with patients displaying motor control symptoms, and the other where the symptoms were purely cognitive.

Interestingly, the amounts of alpha-synuclein in the blood samples from individuals with motor symptoms were significantly higher than both healthy participants as well as PD patients with symptoms of dementia.

Does this mean a routine blood test for diagnosing PD is just around the corner? Probably not. The complexity of the molecular players involved and their contribution to the resulting disease symptoms remain a major barrier. However, the accuracy and reliability with which the alpha-synuclein test could identify patients within a subgroup of PD patients were promising. Also, the level of alpha-synuclein correlated well with the severity of disease symptoms, which would be useful for physicians designing personalized treatment interventions.



Sources: Parkinson’s News Today, Annals of Clinical and Translational Neurology.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 14, 2020
Health & Medicine
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
SEP 14, 2020
Direct Amplification: Rapid, Extraction-Free RT-qPCR Results
As the SARS-CoV-2 pandemic continues to rage across the United States and around the globe, the demand for COVID-19 test ...
OCT 21, 2020
Cell & Molecular Biology
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
OCT 21, 2020
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
During a heart attack, blood flow is blocked and cells lose oxygen and begin to die. Scientists are developing many new ...
NOV 03, 2020
Cell & Molecular Biology
The Connections Between Toxins, Genes, and Disease
NOV 03, 2020
The Connections Between Toxins, Genes, and Disease
We are exposed to a vast array of chemicals every day. Many are harmless or even important, like the air we breathe, wat ...
NOV 13, 2020
Cell & Molecular Biology
Astrocytes are Star Players in the Brain
NOV 13, 2020
Astrocytes are Star Players in the Brain
As neurons fire, they enable us to think and move. They signal to one another where they meet at synapses, and at chemic ...
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
NOV 16, 2020
Cell & Molecular Biology
How Gut Microbes Deactivate a Common Diabetes Drug
NOV 16, 2020
How Gut Microbes Deactivate a Common Diabetes Drug
Metformin is a frequently prescribed type 2 diabetes treatment but its effects can vary significantly. In some patients ...
Loading Comments...